Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The hydrogel effectively stops bleeding and heals diabetic wounds quickly.

Biologics for severe asthma have known side effects, but some new risks need more study.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

GPIGS peptide increases thick hair growth in balding Japanese men.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

A new model helps predict treatment success in girls with early puberty.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

Engineered polypeptide-based systems can improve cancer treatment by targeting specific sites and reducing side effects.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.